277 related articles for article (PubMed ID: 26373564)
1. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics.
Barthel D; Ganser G; Kuester RM; Onken N; Minden K; Girschick HJ; Hospach A; Horneff G
J Rheumatol; 2015 Nov; 42(11):2160-5. PubMed ID: 26373564
[TBL] [Abstract][Full Text] [Related]
2. Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept.
van Dijken TD; Vastert SJ; Gerloni VM; Pontikaki I; Linnemann K; Girschick H; Armbrust W; Minden K; Prince FH; Kokke FT; Nieuwenhuis EE; Horneff G; Wulffraat NM
J Rheumatol; 2011 Jul; 38(7):1441-6. PubMed ID: 21459936
[TBL] [Abstract][Full Text] [Related]
3. [Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis].
Minden K; Klotsche J; Niewerth M; Horneff G; Zink A
Z Rheumatol; 2013 May; 72(4):339-46. PubMed ID: 23456365
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
5. Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis.
Kok VC; Horng JT; Huang JL; Yeh KW; Gau JJ; Chang CW; Zhuang LZ
BMC Cancer; 2014 Aug; 14():634. PubMed ID: 25174953
[TBL] [Abstract][Full Text] [Related]
6. Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.
Southwood TR; Foster HE; Davidson JE; Hyrich KL; Cotter CB; Wedderburn LR; Hull RG; Venning HE; Rahman JK; Cummins CL;
Rheumatology (Oxford); 2011 Jan; 50(1):189-95. PubMed ID: 21047801
[TBL] [Abstract][Full Text] [Related]
7. The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association.
Demirkaya E; Ozen S; Bilginer Y; Ayaz NA; Makay BB; Unsal E; Erguven M; Poyrazoglu H; Kasapcopur O; Gok F; Akman S; Balat A; Cavkaytar O; Kaya B; Duzova A; Ozaltin F; Topaloglu R; Besbas N; Bakkaloglu A; Arisoy N; Ozdogan H; Bakkaloglu S; Turker T
Clin Exp Rheumatol; 2011; 29(1):111-6. PubMed ID: 21269582
[TBL] [Abstract][Full Text] [Related]
8. Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.
van Dijk BT; Bergstra SA; van den Berg JM; Schonenberg-Meinema D; van Suijlekom-Smit LWA; van Rossum MAJ; Koopman-Keemink Y; Ten Cate R; Allaart CF; Brinkman DMC; Hissink Muller PCE
Pediatr Rheumatol Online J; 2024 May; 22(1):53. PubMed ID: 38730442
[TBL] [Abstract][Full Text] [Related]
9. Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).
Davies R; Carrasco R; Foster HE; Baildam EM; Chieng SEA; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
Semin Arthritis Rheum; 2016 Oct; 46(2):190-195. PubMed ID: 27422803
[TBL] [Abstract][Full Text] [Related]
10. Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients-analysis of the BiKeR registry.
Zimmer A; Klein A; Kuemmerle-Deschner JB; Dressler F; Onken N; Brueck N; Fasshauer M; Hospach T; Hufnagel M; Foell D; Horneff G
Rheumatol Int; 2023 Sep; 43(9):1675-1684. PubMed ID: 37291093
[TBL] [Abstract][Full Text] [Related]
11. Temporomandibular joint arthritis in juvenile idiopathic arthritis: prevalence, clinical and radiological signs, and relation to dentofacial morphology.
Billiau AD; Hu Y; Verdonck A; Carels C; Wouters C
J Rheumatol; 2007 Sep; 34(9):1925-33. PubMed ID: 17696265
[TBL] [Abstract][Full Text] [Related]
12. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis.
Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A
J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559
[TBL] [Abstract][Full Text] [Related]
15. The risk of contracting pediatric inflammatory bowel disease in children with celiac disease, epilepsy, juvenile arthritis and type 1 diabetes--a nationwide study.
Virta LJ; Kolho KL
J Crohns Colitis; 2013 Feb; 7(1):53-7. PubMed ID: 22445838
[TBL] [Abstract][Full Text] [Related]
16. Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study.
Leiskau C; Thon A; Gappa M; Dressler F
Clin Exp Rheumatol; 2012; 30(2):302-7. PubMed ID: 22409955
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study.
Dallocchio A; Canioni D; Ruemmele F; Duquesne A; Scoazec JY; Bouvier R; Paraf F; Languepin J; Wouters CH; Guillot M; Quartier P; Bader-Meunier B;
Rheumatology (Oxford); 2010 Sep; 49(9):1694-8. PubMed ID: 20472717
[TBL] [Abstract][Full Text] [Related]
18. Etanercept treatment for children with refractory juvenile idiopathic arthritis.
Kuo HC; Yu HR; Wu CC; Chang LS; Yang KD
J Microbiol Immunol Infect; 2011 Feb; 44(1):52-6. PubMed ID: 21531353
[TBL] [Abstract][Full Text] [Related]
19. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment.
Beukelman T; Xie F; Chen L; Baddley JW; Delzell E; Grijalva CG; Lewis JD; Ouellet-Hellstrom R; Patkar NM; Saag KG; Winthrop KL; Curtis JR;
Arthritis Rheum; 2012 Aug; 64(8):2773-80. PubMed ID: 22569881
[TBL] [Abstract][Full Text] [Related]
20. The use of methotrexate in children with rheumatic diseases.
Gutiérrez-Suárez R; Burgos-Vargas R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]